DB00022 sequence CDLPQTHSLGSRRTLMLLAQMRRISLFSCLKDRHDFGFPQEEFGNQFQKAETIPVLHEMI QQIFNLFSTKDSSAAWDETLLDKFYTELYQQLNDLEACVIQGVGVTETPLMKEDSILAVR KYFQRITLYLKEKKYSPCAWEVVRAEIMRSFSLSTNLQESLRSKE
CDLPQTHSLG SRRTLMLLAQ MRRISLFSCL KDRHDFGFPQ EEFGNQFQKA ETIPVLHEMI
QQIFNLFSTK DSSAAWDETL LDKFYTELYQ QLNDLEACVI QGVGVTETPL MKEDSILAVR
KYFQRITLYL KEKKYSPCAW EVVRAEIMRS FSLSTNLQES LRSKE
Chemical structure of peginterferon α-2a and α-2b. Abbreviations: PeG-IFN, peginterferon; IFN, interferon; Lys, lysine; His, histidine; Cys, cysteine; Ser, serine.
Pegylated Interferon alpha-2b
(PegIFN), Virafin
| Formula | C860H1353N229O255S9 |
|---|---|
| CAS | 99210-65-8,98530-12-2, 215647-85-1 |
| Mol weight | 19268.9111 |
- Interferon α2b, pegylated
- PegIFN a-2b
- PegIFN a-2b (biologics)
- PegIFN α-2b
- PegIntron
- Pegaferon
- PegiHep
- Peginterferon alfa-2b
- Peginterferon α-2b
- Pegylated interferon alfa-2b
- Pegylated interferon α-2b
- Pegylated interferons, PegIFN a-2b
- Proteinaceous biopharmaceuticals, PegIFN a-2b
- Sch 54031
- Sylatron
- ViraferonPeg
Active Moieties
| NAME | KIND | UNII | CAS | INCHI KEY |
|---|---|---|---|---|
| Interferon alfa-2b | unknown | 43K1W2T1M6 | 98530-12-2 | Not applicable |
| Clinical data | |
|---|---|
| Trade names | PegIntron, Sylatron, ViraferonPeg, others |
| AHFS/Drugs.com | Professional Drug Facts |
| MedlinePlus | a605030 |
| License data | EUEMA:by INN |
| Routes of administration | Subcutaneous injection |
| ATC code | L03AB10(WHO) |
| Legal status | |
| Legal status | US:℞-only[1][2]EU: |
View original post 4,749 more words
DRUG REGULATORY AFFAIRS INTERNATIONAL 